The Trump administration’s proposed tariffs on imported goods from Canada and Mexico may currently be on pause, but uncertainty over their potential reinstatement is having a ripple effect across the healthcare and pharmaceutical industries.

An additional 10% tariff on Chinese imports went into effect on Tuesday.

Hospitals and drugmakers are urging the president to exempt pharmaceuticals and medical goods from his new tariffs on Chinese imports.